Efficacy and safety of triple combination therapy with transarterial chemoembolization (TACE), tyrosine kinase inhibitor (TKI), and immune checkpoint inhibitor (ICI) versus dual combination therapy in unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis

被引：0
|
作者：
Maano, O. P. [1 ]
Malbas, J. M. V. [1 ]
Dy, C. [1 ]
机构：
[1] St Lukes Med Ctr Quezon City, Canc Inst, Quezon City, Philippines
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2147
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1003P
引用
收藏
页码：S614 / S614
页数：1
相关论文
共 50 条
  • [41] Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    Meng, Mao-Bin
    Cui, Yao-Li
    Lu, You
    She, Bin
    Chen, Yan
    Guan, Yong-Song
    Zhang, Rui-Ming
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 (02) : 184 - 194
  • [42] Triple combination of HAIC-FO plus tyrosine kinase inhibitors and immune checkpoint inhibitors for advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Tan, Zhongbao
    Zhang, Jian
    Xu, Lan
    Wang, Huanjing
    Mao, Xuequn
    Zou, Rong
    Wang, Qingqing
    Han, Zhuang
    Di, Zhenhai
    Wu, Daguang
    PLOS ONE, 2023, 18 (10):
  • [43] VIRAL ETIOLOGY DETERMINES OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR-BASED COMBINATION THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Wu, Chi-Jung
    Lee, Pei-Chang
    Hung, Ya-Wen
    Lee, Chieh-Ju
    Chi, Chen-Ta
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    HEPATOLOGY, 2022, 76 : S1376 - S1376
  • [44] Combination of transarterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) compared to TACE alone as bridging therapy transplant recipients with hepatocellular carcinoma: An update.
    Esmail, Abdullah
    Victor, David
    Kodali, Sudha
    Graviss, Edward A.
    Nguyen, Duc T.
    Moore, Linda W.
    Saharia, Ashish
    McMillan, Robert
    Fong, Joy N.
    Uosef, Ahmed
    Elshawwaf, Mahmoud
    Heyne, Kirk
    Ghobrial, Rafik Mark
    Abdelrahim, Maen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16201 - E16201
  • [45] Clinical efficacy and safety of immune checkpoint inhibitor in combination with regor-afenib therapy as second. line regimen for patients with unresectable hepatocellular carcinoma
    Li, Jinpeng
    Jia, Yuntao
    Song, Jinlong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    An-ju Tan
    Dun-chang Mo
    Ka Wu
    Hong-mei Pan
    Dong-mei Wang
    Xing-xin Xu
    Min-hong Chen
    Shu-ying Pan
    Rou Li
    Wen-jiao lian
    Meng-han Wei
    World Journal of Urology, 2023, 41 : 1563 - 1571
  • [47] Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis
    Abuelazm, Mohamed T.
    Abdelazeem, Basel
    Badr, Helmy
    Gamal, Mohamed
    Ashraf, Mohamed
    Abd-elsalam, Sherief
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2022, 27 (03) : 226 - 235
  • [48] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    Tan, An-ju
    Mo, Dun-chang
    Wu, Ka
    Pan, Hong-mei
    Wang, Dong-mei
    Xu, Xing-xin
    Chen, Min-hong
    Pan, Shu-ying
    Li, Rou
    Lian, Wen-jiao
    Wei, Meng-han
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1563 - 1571
  • [49] Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis
    Si, Tengfei
    Huang, Zhenlin
    Khorsandi, Shirin Elizabeth
    Ma, Yun
    Heaton, Nigel
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [50] Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis
    Department of Inflammation Biology, Faculty of Life Sciences Medicine, Institute of Liver Studies, King’s College Hospital, King’s College London, Denmark Hill, London, United Kingdom
    不详
    不详
    不详
    Front. Bioeng. Biotechnol., 2022,
12345